Low erythropoietin production as non-oncogenic co-factor contributing to disease-manifestation in low-risk MDS: A hypothesis supported by unique case reports-Reference-Cited by-同舟云学术

Low erythropoietin production as non-oncogenic co-factor contributing to disease-manifestation in low-risk MDS: A hypothesis supported by unique case reports

Published:2008-09 Issue:9 Volume:32 Page:1333-1337
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Valent Peter

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference13 articles.

1. Proposals for the classification of the myelodysplastic syndromes;Bennett;Br J Haematol,1982

2. Morphology and classification of the myelodysplastic syndromes and their pathologic variants;Kouides;Semin Hematol,1996

3. Myelodysplastic syndromes;Brunning,2001

4. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference;Valent;Leuk Res,2007

5. Normal bone marrow function over 6 years in a patient with dysplastic hematopoiesis and a complex karyotype;Valent;Leuk Res,2004

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anaemia in the Elderly: A Narrative Review;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2023

2. Unexplained Anemia in the Elderly;Cureus;2021-11-28

3. Erythropoietin levels and erythroid differentiation parameters in patients with lower-risk myelodysplastic syndromes;Leukemia Research;2018-08

4. Anemia at older age: etiologies, clinical implications, and management;Blood;2018-02-01

5. Pro-inflammatory proteins S100A9 and tumor necrosis factor-α suppress erythropoietin elaboration in myelodysplastic syndromes;Haematologica;2017-10-05